PharmaMar announces data presentations: Yondelis® and lurbinectedin at

(Pharmamar) During the Congress of the American Society of Clinical Oncology (ASCO) that will be held form the June 1-5 in Chicago (USA), PharmaMar will present the data obtained from various clinical studies of the molecules Yondelis ®, lurbinectedin (PM1183) and plitidepsin.

PharmaMar announces data presentations: Yondelis® and lurbinectedin at ASCO

Related Posts

Mount Sinai Experts to Unveil New AI Model Predicting Lung Nodule Risk and Study Effects of Air Pollution During Pregnancy at ATS 2026 International Conference

From Silkworms to Supermaterials: A Scientific Breakthrough

LMNA Variant and Polymorphisms Trigger Early Atrial Fibrillation

AI System Enhances Expert Software Research Writing

POPULAR NEWS

Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

New Study Reveals Plants Can Detect the Sound of Rain

Salmonella Haem Blocks Macrophages, Boosts Infection

Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

About

Follow us

Recent News

Compounding Hazards Amplify Europe’s Flood Costs

New Houston Methodist Study Reveals Rising Breast Cancer Risk Among Younger Women and Enhanced Outcomes for Older Patients

Mount Sinai Experts to Unveil New AI Model Predicting Lung Nodule Risk and Study Effects of Air Pollution During Pregnancy at ATS 2026 International Conference

Subscribe to Blog via Email

Welcome Back!

Retrieve your password